VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OSRH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
OSRHOSR Holdings, Inc.
$0.31$1M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

OSRH logoOSR Holdings, Inc.(OSRH)Earnings, Financials & Key Ratios

OSRH•NASDAQ
$0.31
Price updated Jul 7, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryCommercial Specialty Pharma
AboutOSR Holdings, Inc. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.Show more
  • Revenue$3M-17.7%
  • EBITDA-$9M-351.3%
  • Net Income-$18M-74.4%
  • EPS (Diluted)-4.02-644.4%
  • Gross Margin20.4%-11.2%
  • EBITDA Margin-310.75%-448.3%
  • Operating Margin-631.01%-90.5%
  • Net Margin-619.82%-111.8%
  • ROE-29.88%+62.3%

OSRH Price & Volume

OSR Holdings, Inc. (OSRH) stock price & volume — 10-year historical chart

Loading chart...

Persistent Liquidity Constraints Threaten OSRH Operational Viability

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity depletion risk

Key Thesis Takeaways

  • OSRH faces a precarious outlook as its transition from a blank check entity has failed to establish a repeatable commercial model, evidenced by a 36.4% year-over-year revenue decline in 2026Q1.
  • The company's reliance on administrative overhead over clinical R&D, coupled with a critical liquidity position, suggests significant risk of further equity dilution or insolvency.
  • Investors should remain cautious as the firm struggles to convert its $29.7M in goodwill into tangible operational value.

Verdict Logic

the company's inability to sustain operations is highlighted by a -631.01% operating margin and a critical liquidity shortfall that threatens its status as a going concern.

OSRH Growth Metrics

OSR Holdings, Inc. (OSRH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM355.01%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-66.93%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM9.47%

Return on Capital

10 Years-366.15%
5 Years-38.54%
3 Years-37.52%
Last Year-24.5%

Latest OSRH News

Recent stock market news and headlines for OSR Holdings, Inc. (OSRH)

Accesswire·6 days ago
Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

NEW YORK CITY, NY / ACCESS Newswire / July 2, 2026 / Emerging Growth Research today issued a flash report on OSR Health, Inc. (NASDAQ:OSRH), formerly OSR Holdings, reaffirming its Buy-Emerging rating and 12-month price target of $10.00. The flash report highlights OSRH's newly announced Shareholder Loyalty Program, a novel plan to reward long-term shareholders with Contingent Value Rights ("CVR") rather than pursuing a reverse stock split.

Accesswire·Jun 25, 2026
OSR Health Announces Shareholder Loyalty Program to Reward Conviction Holders With Additional Shares

Contingent Value Rights would reward continuous holders with additional shares as the Company meets defined price milestones BELLEVUE, WA / ACCESS Newswire / June 25, 2026 / OSR Health, Inc. (NASDAQ:OSRH) today announced a Shareholder Loyalty Program designed to reward the investors who hold OSRH stock over the long term. Under the program, the Company plans to distribute non-transferable Contingent Value Rights ("CVRs") to all shareholders of record tentatively as of July 31, 2026.

Accesswire·Jun 22, 2026
OSR Holdings Is Now OSR Health - A New Name That Says Exactly What We Do

BELLEVUE, WA / ACCESS Newswire / June 22, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced that it has officially changed its corporate name to OSR Health, Inc., a fresh identity that more directly reflects the Company's mission. The change became effective on June 11, 2026 upon the filing of a Certificate of Amendment with the Delaware Secretary of State.

Peers Comparison

Key metrics vs top competitors for OSR Holdings, Inc. (OSRH)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
OSRH logoOSRHOSR Holdings, Inc.Current
$0.31$1.41M-0.08-17.69%-619.82%-29.88%—
HCWB logoHCWBHCW Biologics Inc.
$4.47$1.55M-0.07-97.89%-24.73%-102.39%—
AEYE logoAEYEAudioEye, Inc.
$7.41$92.58M-29.6414.52%-9.05%-70.95%—
NXPL logoNXPLNextPlat Corp
$7.14$19.34M-1.59-17.04%-23.14%-58.05%—
CLPS logoCLPSCLPS Incorporation
$0.84$24.98M-3.2315.17%-3.05%-15.02%—
CODA logoCODACoda Octopus Group, Inc.
$9.30$104.91M25.1430.75%17.66%8.33%—

Compare OSRH vs Peers

OSR Holdings, Inc. (OSRH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HCWB

Most directly comparable listed peer for OSRH.

Scale Benchmark

vs GOOGL

Larger-name benchmark to compare OSRH against a more recognizable public peer.

Peer Set

Compare Top 5

vs HCWB, AEYE, NXPL, CLPS

OSRH SEC Filings & Documents

OSR Holdings, Inc. (OSRH) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 30, 2026·SEC

Material company update

Apr 22, 2026·SEC

Material company update

Apr 9, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 31, 2026·SEC

FY 2025

Apr 22, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

May 13, 2026·SEC

FY 2025

Nov 12, 2025·SEC

FY 2025

Aug 14, 2025·SEC

Get notified when OSRH posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

OSRH Frequently Asked Questions

OSR Holdings, Inc. (OSRH) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is OSR Holdings, Inc.'s revenue?

OSR Holdings, Inc. (OSRH) reported $2.6M in revenue for fiscal year 2025.

How fast is OSR Holdings, Inc. growing?

OSR Holdings, Inc. (OSRH) saw revenue decline by 17.7% over the past year.

Is OSRH profitable?

OSR Holdings, Inc. (OSRH) reported a net loss of $13.8M for fiscal year 2025.

Dividend & Returns
What is OSRH's return on equity?

OSR Holdings, Inc. (OSRH) has a return on equity (ROE) of -29.9%. Negative ROE indicates the company is unprofitable.

What is OSR Holdings, Inc.'s free cash flow?

OSR Holdings, Inc. (OSRH) had negative free cash flow of $5.4M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in OSRH back in 2020?

Total return calculator · dividends reinvested · 6+ years of data

See returns →